The livestock vaccine market is predicted to be valued at US$ 6.1 billion in 2024 and rise to US$ 11.2 billion by 2034. The market is expected to grow at a CAGR of 6.2% during the forecast period.
Key Market Drivers
With the objective of giving the animal a vaccine to stimulate the immune system to form antibodies for the upliftment of their well-being, there is a huge rise in the livestock vaccine market. Some factors are mentioned below-
Attributes | Key Statistics |
---|---|
Live Stock Vaccine Market Value (2024) | US$ 6.1 billion |
Anticipated Market Value (2034) | US$ 11.2 billion |
Estimated Growth (2024 to 2034) | 6.2 % CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Despite the healthy growth of the livestock vaccine market in healthcare sectors, several factors are slowing down the market.
Inactivate vaccines ensure quality assurance and validation, upsurging the global livestock vaccine market with a 6.0% CAGR through 2034.
Attributes | Details |
---|---|
Top Type | Inactivated |
CAGR (2024 to 2034) | 6.0% |
Bovine vaccines are crucial in economic and productivity concerns, heightening the global livestock vaccine market by 5.8% CAGR from 2024 to 2034.
Attributes | Details |
---|---|
Top Animal Type | Bovine |
CAGR (2024 to 2034) | 5.8% |
The section analyzes the global livestock vaccine market by country, including the United Kingdom, the United States, China, South Korea, and Japan.
The table presents the CAGR for each country, indicating the expected market growth through 2034.
Countries | CAGR (2024 to 2034) |
---|---|
South Korea | 8.0% |
Japan | 7.9% |
United Kingdom | 7.4% |
China | 6.8% |
United States | 6.4% |
With growing demand for personalized medicine and advancements in precision healthcare, South Korea is well-positioned to capitalize on the opportunities presented by the expanding global livestock vaccine market with a CAGR of 8.0% from 2024 to 2034.
South Korea is investing in research and development to create innovative vaccine solutions to cater to the needs of the livestock sector. The market presents opportunities for collaborations with global vaccine manufacturers to introduce advanced technologies, expansion of vaccine production capabilities to meet both domestic and international demand, and the adoption of digital solutions for efficient vaccine distribution and administration.
South Korea's innovation in the field includes the development of novel vaccine delivery systems such as edible vaccines that offer convenience and improved efficacy. Future plans involve partnerships between public and private sectors to establish advance vaccine manufacturing facilities and enhance biosecurity measures to prevent disease outbreaks.
Japan is flourishing in the livestock vaccine market due to the country's growing emphasis on food safety, animal health, and sustainable agriculture. The market has a CAGR of 7.9%, which is expected to continue through 2034.
Japan is investing heavily in research and development, with a particular focus on improving the efficacy and safety of livestock vaccines. Collaboration between government agencies, academic institutions, and pharmaceutical companies is also on the rise, as they work together to create innovative vaccine solutions customized to meet the unique needs of the local livestock industry.
Notable organizations driving this growth include the National Institute of Animal Health and the Japan Livestock Technology Association, both actively engaged in vaccine research and development.
The livestock vaccine market in the United Kingdom is projected to expand at a CAGR of 7.4% through 2034.
The United Kingdom is expanding with increased awareness of animal health and welfare. Growing Concerns about zoonotic diseases and government initiatives to support sustainable agriculture are uplifting the market growth. The United Kingdom is approaching this expansion by investing in research and development, fostering collaborations between academia and industry, and implementing regulatory measures to ensure the safety and efficacy of veterinary vaccines.
Famous centers such as the Pirbright Institute and the Roslin Institute play a crucial role in vaccine research and development, contributing to the expansion of the market. Upcoming projects like the United Kingdom Vaccine Manufacturing and Innovation Centre (VMIC) aim to strengthen the country's vaccine manufacturing capabilities and support the production of vaccines for livestock diseases.
China is emerging as a key player in the livestock vaccine market. The market is projected to rise at a CAGR of 6.8% from 2024 to 2034. China is in a steady race to improve its veterinary healthcare sector.
Chinese government has made considerable efforts and investments in veterinary vaccines, prioritizing the health of livestock and food safety. These initiatives include research and development aimed at innovating vaccine formulations to tackle local disease challenges and production systems.
China has been actively promoting the use of vaccination programs among livestock producers through subsidies and educational campaigns, resulting in increased adoption rates. The demand for animal protein is also on the rise, along with the growth of the livestock industry leading to an escalating need for effective disease prevention measures in China.
Ongoing advancement and research in the United States soar market growth, with an expected CAGR of 6.4% until 2034.
The livestock vaccine market in the United States is expanding due to several factors. Innovative developments in veterinary vaccines, such as the introduction of novel formulations and delivery methods, have spurred growth by enhancing vaccine efficacy and safety. Research projects focused on improving disease prevention and management have contributed to market expansion, with initiatives aimed at addressing emerging livestock diseases and increasing vaccine accessibility.
Notable companies driving this growth include Zoetis, Merck Animal Health, and Elanco, which have a strong presence in the United States to develop cutting-edge vaccine solutions tailored to the needs of American livestock producers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Manufacturers and major companies are taking proactive measures to expand their market presence, as they are witnessing high demand in the livestock vaccine market. Companies such as Zoetis, Merck Animal Health, and Elanco are investing in research and development to create innovative vaccine formulations and delivery methods, which enhance the efficacy and safety of the vaccines.
With the growing global demand for protein-rich diets and increased awareness of animal health and welfare, there are significant opportunities for manufacturers to capitalize on the expanding livestock vaccine market. Some of the emerging trends in this market, such as personalized vaccination programs and the development of vaccines for emerging diseases, present promising avenues for growth and differentiation.
Recent Developments
The livestock vaccine market is projected to be worth US$ 6.1 billion in 2024.
The market is expected to reach US$ 11.2 billion by 2034.
The market is expected to grow at a CAGR of 6.2% from 2024 to 2034.
Boehringer Ingelheim International GmbH, Virbac, Merck Animal Health, Ceva, and Elanco are among the major companies actively contributing to the growth of the global livestock vaccine market.
Increasing demand for animal protein is accelerating the demand for livestock vaccines.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.1.2. Mid-Level Participants (Traders) 3.5.1.3. Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Distributors 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Vials) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Type, 2024 to 2034 5.3.1. Inactivated 5.3.2. Live Attenuated 5.3.3. Recombinant 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Animal Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Animal Type, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Animal Type, 2024 to 2034 6.3.1. Bovine 6.3.2. Swine/ Porcine 6.3.3. Poultry 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Animal Type, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Route of Administration, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Route of Administration, 2024 to 2034 7.3.1. Oral 7.3.2. Parenteral 7.3.3. Others 7.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Route of Administration, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Distribution Channel, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Distribution Channel, 2024 to 2034 8.3.1. Veterinary Hospitals 8.3.2. Veterinary Clinics 8.3.3. Others 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Region, 2019 to 2023 9.3. Current Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Type 10.2.3. By Animal Type 10.2.4. By Route of Administration 10.2.5. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Animal Type 10.3.4. By Route of Administration 10.3.5. By Distribution Channel 10.4. Key Takeaways 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Type 11.2.3. By Animal Type 11.2.4. By Route of Administration 11.2.5. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Animal Type 11.3.4. By Route of Administration 11.3.5. By Distribution Channel 11.4. Key Takeaways 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Type 12.2.3. By Animal Type 12.2.4. By Route of Administration 12.2.5. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Animal Type 12.3.4. By Route of Administration 12.3.5. By Distribution Channel 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Type 13.2.3. By Animal Type 13.2.4. By Route of Administration 13.2.5. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Animal Type 13.3.4. By Route of Administration 13.3.5. By Distribution Channel 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Type 14.2.3. By Animal Type 14.2.4. By Route of Administration 14.2.5. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Animal Type 14.3.4. By Route of Administration 14.3.5. By Distribution Channel 14.4. Key Takeaways 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Type 15.2.3. By Animal Type 15.2.4. By Route of Administration 15.2.5. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Type 15.3.3. By Animal Type 15.3.4. By Route of Administration 15.3.5. By Distribution Channel 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Type 16.2.3. By Animal Type 16.2.4. By Route of Administration 16.2.5. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Type 16.3.3. By Animal Type 16.3.4. By Route of Administration 16.3.5. By Distribution Channel 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2023 17.1.2.1. By Type 17.1.2.2. By Animal Type 17.1.2.3. By Route of Administration 17.1.2.4. By Distribution Channel 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2023 17.2.2.1. By Type 17.2.2.2. By Animal Type 17.2.2.3. By Route of Administration 17.2.2.4. By Distribution Channel 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2023 17.3.2.1. By Type 17.3.2.2. By Animal Type 17.3.2.3. By Route of Administration 17.3.2.4. By Distribution Channel 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2023 17.4.2.1. By Type 17.4.2.2. By Animal Type 17.4.2.3. By Route of Administration 17.4.2.4. By Distribution Channel 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2023 17.5.2.1. By Type 17.5.2.2. By Animal Type 17.5.2.3. By Route of Administration 17.5.2.4. By Distribution Channel 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2023 17.6.2.1. By Type 17.6.2.2. By Animal Type 17.6.2.3. By Route of Administration 17.6.2.4. By Distribution Channel 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2023 17.7.2.1. By Type 17.7.2.2. By Animal Type 17.7.2.3. By Route of Administration 17.7.2.4. By Distribution Channel 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2023 17.8.2.1. By Type 17.8.2.2. By Animal Type 17.8.2.3. By Route of Administration 17.8.2.4. By Distribution Channel 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2023 17.9.2.1. By Type 17.9.2.2. By Animal Type 17.9.2.3. By Route of Administration 17.9.2.4. By Distribution Channel 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2023 17.10.2.1. By Type 17.10.2.2. By Animal Type 17.10.2.3. By Route of Administration 17.10.2.4. By Distribution Channel 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2023 17.11.2.1. By Type 17.11.2.2. By Animal Type 17.11.2.3. By Route of Administration 17.11.2.4. By Distribution Channel 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2023 17.12.2.1. By Type 17.12.2.2. By Animal Type 17.12.2.3. By Route of Administration 17.12.2.4. By Distribution Channel 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2023 17.13.2.1. By Type 17.13.2.2. By Animal Type 17.13.2.3. By Route of Administration 17.13.2.4. By Distribution Channel 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2023 17.14.2.1. By Type 17.14.2.2. By Animal Type 17.14.2.3. By Route of Administration 17.14.2.4. By Distribution Channel 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2023 17.15.2.1. By Type 17.15.2.2. By Animal Type 17.15.2.3. By Route of Administration 17.15.2.4. By Distribution Channel 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2023 17.16.2.1. By Type 17.16.2.2. By Animal Type 17.16.2.3. By Route of Administration 17.16.2.4. By Distribution Channel 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2023 17.17.2.1. By Type 17.17.2.2. By Animal Type 17.17.2.3. By Route of Administration 17.17.2.4. By Distribution Channel 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2023 17.18.2.1. By Type 17.18.2.2. By Animal Type 17.18.2.3. By Route of Administration 17.18.2.4. By Distribution Channel 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2023 17.19.2.1. By Type 17.19.2.2. By Animal Type 17.19.2.3. By Route of Administration 17.19.2.4. By Distribution Channel 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2023 17.20.2.1. By Type 17.20.2.2. By Animal Type 17.20.2.3. By Route of Administration 17.20.2.4. By Distribution Channel 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2023 17.21.2.1. By Type 17.21.2.2. By Animal Type 17.21.2.3. By Route of Administration 17.21.2.4. By Distribution Channel 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2023 17.22.2.1. By Type 17.22.2.2. By Animal Type 17.22.2.3. By Route of Administration 17.22.2.4. By Distribution Channel 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2023 17.23.2.1. By Type 17.23.2.2. By Animal Type 17.23.2.3. By Route of Administration 17.23.2.4. By Distribution Channel 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Type 18.3.3. By Animal Type 18.3.4. By Route of Administration 18.3.5. By Distribution Channel 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Boehringer Ingelheim International GmbH 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. Virbac 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Merck Animal Health (Merck & Co., Inc.) 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. Zoetis Services LLC 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. Ceva 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. Elanco 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. HIPRA 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. Neogen Corporation 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. Dechra Pharmaceuticals PLC 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. Biogénesis Bagó 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports